Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and ...

As the adoption of Artificial Intelligence (AI) in telecommunications accelerates, the importance of ensuring trust and security in cellular wireless networks has never been greater. Today, 5G ...

Detailed price information for Maple Gold Mines Ltd (MGMLF) from The Globe and Mail including charting and trades.

After one long, cold final night fighting through light winds off the Brittany coast, Charlie Dalin, the French skipper of MACIF Santé Prévoyance crossed the Vendée Globe finish line this Tuesday ...

At the time of recording this, Charlie Dalin on MACIF Santé Prévoyance has just 14 nautical miles to go to finish the Vendée Globe and set a staggering new record, taking over 9 days off the previous ...

The danger of this approach is that it effectively provides no protection against disinformation: it is instead primarily geared at driving user engagement. ‘Evil thrives when good people do nothing’, ...

FOXBOROUGH — Mike Vrabel still has plenty to sort out in his new role as Patriots coach, but he already has a vision for his program. “I want to galvanize our football team,” Vrabel said ...

ST. PAUL — Minnesota Farmers Union is preparing to advocate for a strong agriculture budget, affordable healthcare, support for beginning farmers and other priorities during the 2025 Minnesota ...

2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics ...

Topline data from the first Phase 3 FOS study anticipated in H2 2025 representing major milestone in support of NDA filing and potential launch of azetukalner VANCOUVER, British Columbia and BOSTON, ...

2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with ...

SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...